Correlation Between Astellas Pharma and Biogen
Can any of the company-specific risk be diversified away by investing in both Astellas Pharma and Biogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Astellas Pharma and Biogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Astellas Pharma and Biogen Inc, you can compare the effects of market volatilities on Astellas Pharma and Biogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Astellas Pharma with a short position of Biogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Astellas Pharma and Biogen.
Diversification Opportunities for Astellas Pharma and Biogen
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Astellas and Biogen is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Astellas Pharma and Biogen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biogen Inc and Astellas Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Astellas Pharma are associated (or correlated) with Biogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biogen Inc has no effect on the direction of Astellas Pharma i.e., Astellas Pharma and Biogen go up and down completely randomly.
Pair Corralation between Astellas Pharma and Biogen
Assuming the 90 days horizon Astellas Pharma is expected to generate 0.88 times more return on investment than Biogen. However, Astellas Pharma is 1.14 times less risky than Biogen. It trades about -0.01 of its potential returns per unit of risk. Biogen Inc is currently generating about -0.06 per unit of risk. If you would invest 882.00 in Astellas Pharma on December 29, 2024 and sell it today you would lose (15.00) from holding Astellas Pharma or give up 1.7% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 98.44% |
Values | Daily Returns |
Astellas Pharma vs. Biogen Inc
Performance |
Timeline |
Astellas Pharma |
Biogen Inc |
Astellas Pharma and Biogen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Astellas Pharma and Biogen
The main advantage of trading using opposite Astellas Pharma and Biogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Astellas Pharma position performs unexpectedly, Biogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will offset losses from the drop in Biogen's long position.Astellas Pharma vs. Nufarm Limited | Astellas Pharma vs. ALLFUNDS GROUP EO 0025 | Astellas Pharma vs. Penta Ocean Construction Co | Astellas Pharma vs. Diversified Healthcare Trust |
Biogen vs. MCEWEN MINING INC | Biogen vs. ARDAGH METAL PACDL 0001 | Biogen vs. GREENX METALS LTD | Biogen vs. The Japan Steel |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |